Liquid Dosage
With diabetes on the rise and the global insulin market estimated to be worth more than $32 billion by 2018, demand for GEA technologies for the production of this life-saving drug is already high and set to increase, particularly in new markets and emerging economies.
GEA produces and supplies process systems for the production of liquid products for the pharmaceutical and biotechnological industries, and has a proven history of successfully installing plant for the production of insulin, including the engineering, delivery, commissioning and qualification of entire ultra-pure media systems as well as various process equipment and cleaning installations.
A worldwide technology leader in insulin production, GEA is able to supply the clean utility systems and manage the integration of all the main processes, including fermentation, harvesting, chromatography, filtration and freeze drying.
The biosynthetic production of human insulin is done using bacteria or yeast cells. Following fermentation, or the conversion of chemical raw materials by micro-organisms, the biomass is extracted using a nozzle separator, washed, concentrated and finally precipitated to produce insulin crystals.
Centrifuges and process lines provided by GEA have an established pedigree in the clarification, separation, classification, concentration and fractionation steps. Nozzle separators also play an important part in the production process. Further, GEA chamber or self-cleaning separators can be used in the subsequent crystallization stages.
GEA is a single-source supplier of a variety of fermenters, media preparation, buffer storage, harvesting and cell rupture solutions, equipment for the purification and isolation of cells, separation (after both first and final crystallization), the production and distribution of WFI, CIP and freeze drying technologies, all of which can be installed and integrated into a state-of-the-art insulin production facility.
Visualizzazione di 4 su 14
Le testate di compressione di GEA sono il cuore pulsante dell'omogeneizzatore poiché attivano il processo di omogeneizzazione pompando il prodotto ad alta pressione per convogliarlo all'interno della valvola di omogeneizzazione.
GEA Hilge offre una gamma versatile di pompe centrifughe e volumetriche per un'ampia varietà di applicazioni sensibili nell'industria delle bevande, alimentare e farmaceutica.
GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.
Gli omogeneizzatori da laboratorio GEA, piccoli e compatti, consentono di testare gli effetti dell'omogeneizzazione sul prodotto e valutare quali sono i migliori parametri di processo.
Il cambiamento climatico e la crescita della popolazione mondiale mettono sotto pressione l'industria alimentare, che consuma molta energia, per nutrire più persone senza impattare ulteriormente sul pianeta. George Shepherd, Global Technical Sustainability Manager di GEA, spiega come GEA utilizzi il proprio know-how ingegneristico per aiutare le aziende di trasformazione a produrre in modo più sostenibile, aumentando al contempo la produttività.
The world's population is growing and with it demand for milk. Dairy is an essential component of many global diets. However, its production can be resource-intensive and impact the environment. GEA’s Christian Müller, Senior Director Sustainability Farm Technologies, sheds light on how technological innovations powered by GEA make milk production more efficient and profitable.
Ogni bevanda e alimento sicuro è una vittoria contro invisibili minacce microbiche, il risultato di una battaglia condotta sulla scorta di un secolo di progettazione di processi igienici. Con oltre 100 anni di know-how ingegneristico e di progettazione igienica, GEA stabilisce lo standard industriale per attrezzature di lavorazione che proteggono gli alimenti e salvano vite.